Insights

Expanding Direct-to-Consumer Offerings Novo Nordisk's recent launch of a direct-to-consumer pharmacy featuring Wegovy at $499 per month indicates a strategic shift towards personalized healthcare access, opening opportunities to partner with pharmacies and healthcare providers targeting weight management and chronic disease markets.

Investing in Oral Medications The development of oral GLP-1 medications signifies a focus on more convenient, cost-effective treatments, creating potential for collaborations with pharmaceutical distributors and healthcare systems looking to enhance patient compliance and streamline drug delivery.

Global Market Expansion With recent campaigns and partnerships in India and collaborations with local distributors like Emcure, there are emerging sales opportunities in emerging markets for diabetic and weight-loss therapies as Novo Nordisk seeks to increase global reach.

Pricing and Affordability Strategies Novo Nordisk's commitment to offering Zepbound and Wegovy at 'Most Favored Nation' rates in the US demonstrates a focus on competitive pricing, suggesting opportunities to collaborate on cost-reduction initiatives or access programs to improve market penetration.

Innovative Research and Events Participation in major industry meetings like AASLD and significant press conferences highlights commitment to cutting-edge research, indicating potential engagement opportunities around pioneering treatment solutions and early adoption of new therapies.

Novo Nordisk Tech Stack

Novo Nordisk uses 8 technology products and services including Facebook Pixel, Duda, Font Awesome, and more. Explore Novo Nordisk's tech stack below.

  • Facebook Pixel
    Analytics
  • Duda
    Content Management System
  • Font Awesome
    Font Scripts
  • Microsoft
    Miscellaneous
  • C++
    Programming Languages
  • Akamai mPulse
    Real User Monitoring
  • Cloudflare Bot Management
    Security
  • HSTS
    Security

Media & News

Novo Nordisk's Email Address Formats

Novo Nordisk uses at least 2 format(s):
Novo Nordisk Email FormatsExamplePercentage
FLast@novonordisk.comJDoe@novonordisk.com
80%
First.Last@novonordisk.comJohn.Doe@novonordisk.com
11%
FirstL@novonordisk.comJohnD@novonordisk.com
7%
LastF@novonordisk.comDoeJ@novonordisk.com
2%
First.Last@teamnovonordisk.comJohn.Doe@teamnovonordisk.com
87%
First@teamnovonordisk.comJohn@teamnovonordisk.com
6%
Last@teamnovonordisk.comDoe@teamnovonordisk.com
3%
First.Middle@teamnovonordisk.comJohn.Michael@teamnovonordisk.com
4%

Frequently Asked Questions

Where is Novo Nordisk's headquarters located?

Minus sign iconPlus sign icon
Novo Nordisk's main headquarters is located at Novo Alle Bagsværd, 2880 DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Novo Nordisk's phone number?

Minus sign iconPlus sign icon
You can contact Novo Nordisk's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novo Nordisk's stock symbol?

Minus sign iconPlus sign icon
Novo Nordisk is a publicly traded company; the company's stock symbol is NVO.

What is Novo Nordisk's official website and social media links?

Minus sign iconPlus sign icon
Novo Nordisk's official website is novonordisk.com and has social profiles on LinkedIn.

How much revenue does Novo Nordisk generate?

Minus sign iconPlus sign icon
As of October 2025, Novo Nordisk's annual revenue is estimated to be $5B.

What is Novo Nordisk's NAICS code?

Minus sign iconPlus sign icon
Novo Nordisk's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novo Nordisk have currently?

Minus sign iconPlus sign icon
As of October 2025, Novo Nordisk has approximately 67K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Medical Officer: F. K. K.Chief Financial Officer And Executive Vice President, Finance, Legal & Global Solutions: K. M. K.Chief Patient Officer, Novo Nordisk Rare Disease: I. O.. Explore Novo Nordisk's employee directory with LeadIQ.

What industry does Novo Nordisk belong to?

Minus sign iconPlus sign icon
Novo Nordisk operates in the Pharmaceutical Manufacturing industry.

What technology does Novo Nordisk use?

Minus sign iconPlus sign icon
Novo Nordisk's tech stack includes Facebook PixelDudaFont AwesomeMicrosoftC++Akamai mPulseCloudflare Bot ManagementHSTS.

What is Novo Nordisk's email format?

Minus sign iconPlus sign icon
Novo Nordisk's email format typically follows the pattern of FLast@novonordisk.com. Find more Novo Nordisk email formats with LeadIQ.

How much funding has Novo Nordisk raised to date?

Minus sign iconPlus sign icon
As of October 2025, Novo Nordisk has raised $22M in funding. The last funding round occurred on Dec 05, 2018 for $22M.

When was Novo Nordisk founded?

Minus sign iconPlus sign icon
Novo Nordisk was founded in 1923.
Novo Nordisk

Novo Nordisk

Pharmaceutical ManufacturingBagsværd, Denmark10001+ Employees

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.

This page isn’t intended for discussions about products.  As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. 

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: 
https://www.novonordisk.com/contact-us/find-local-information.html

For other customer complaints, please contact us here: 
https://www.novonordisk.com/contact-us.html

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. 

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Section iconCompany Overview

Headquarters
Novo Alle Bagsværd, 2880 DK
Phone number
Stock Symbol
NVO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1923
Employees
10001+

Section iconFunding & Financials

  • $22M

    Novo Nordisk has raised a total of $22M of funding over 1 rounds. Their latest funding round was raised on Dec 05, 2018 in the amount of $22M.

  • $10B

    Novo Nordisk's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $22M

    Novo Nordisk has raised a total of $22M of funding over 1 rounds. Their latest funding round was raised on Dec 05, 2018 in the amount of $22M.

  • $10B

    Novo Nordisk's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.